Sarah Jane Tribble (page 2)
Drug rebates reward industry players — and often hurt patients
Sarah Jane Tribble
A major drug company left its lobbying group over a drug price controversy
Sarah Jane Tribble
GAO to launch investigation of FDA’s Orphan Drug Program
Sarah Jane Tribble
Page: 2